Download PDF
CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(08): E1018-E1020
DOI: 10.1055/a-1190-4039
Editorial

How do we survey IBD in Japan: chromoendoscopy versus white light?

Yoshitaka Ueno
1   Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan
2   Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan
,
Shinji Tanaka
1   Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Patients with ulcerative colitis (UC) or Crohn’s colitis have an increased risk of colorectal cancer compared with the general population. Because colitis-associated dysplasia is often subtle, flat or not endoscopically identifiable, the first surveillance guidelines recommended sampling four random biopsies from every 10 cm of colon in addition performing targeted biopsies of lesions suspected of containing dysplasia [1].



Publication History

Article published online:
21 July 2020

© 2020. Owner and Copyright ©

© Georg Thieme Verlag KG
Stuttgart · New York

Refers to:

Surveillance in inflammatory bowel disease: is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trialsEndosc Int Open 2020; 08(05): E578-E590
DOI: 10.1055/a-1120-8376

 

  • References

  • 1 Winawer S, Fletcher R, Rex D. et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003; 124: 544-560
    CrossrefPubMedGoogle Scholar
  • 2 Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med 2015; 372: 1441-1452
    CrossrefPubMedGoogle Scholar
  • 3 Ricardo R, Igor R, Diogo M. et al. Surveillance in inflammatory bowel disease: is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trials. Endosc Int Open 2020; 08: 578-590
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Laine L, Kaltenbach T, Barkun A. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 2015; 81: 489-501
    CrossrefPubMedGoogle Scholar
  • 5 Sugimoto S, Naganuma M, Iwao Y. et al. Endoscopic morphologic features of ulcerative colitis–associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc 2017; 85: 639-646
    CrossrefPubMedGoogle Scholar
  • 6 Iacucci M, McQuaid K, Gui XS. et al. A multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy 2019; 51: 133-141
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Feuerstein JD, Rakowsky S, Sattler L. et al. Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer. Gastrointest Endosc 2019; 90: 186-195
    CrossrefPubMedGoogle Scholar
  • 8 Iacucci M, Kaplan GG, Panaccione R. et al. A randomized trial comparing high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy. Am J Gastroenterol 2018; 113: 225-234
    CrossrefPubMedGoogle Scholar
  • 9 Oka S, Uraoka T, Watanabe K. et al. Endoscopic diagnosis and treatment of ulcerative colitis-associated neoplasia. Dig Endosc 2019; 31: 26-30
    CrossrefPubMedGoogle Scholar
  • 10 Watanabe T, Ajioka Y, Mitsuyama K. et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology 2016; 151: 1122-1130
    CrossrefPubMedGoogle Scholar
  • 11 Nishiyama S, Oka S, Tanaka S. et al. Is It possible to discriminate between neoplastic and nonneoplastic lesions in ulcerative colitis by magnifying colonoscopy?. Inflamm Bowel Dis 2014; 20: 508-513
    CrossrefPubMedGoogle Scholar